Chief Judge Leads Federal Circuit in Reconsidering its Appetite for Skinny Labels

Published date04 March 2021
Subject MatterPatents,Hatch-Waxman,Prescription Drugs,Generic Drugs,Patent Litigation,Pharmaceutical Patents,Patent Infringement,Product Labels,Pharmaceutical Industry
AuthorKatherine Helm Ph.D.,Brian Goldberg
Law FirmDechert LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT